Aminoglycoside modifying enzymes (AMEs) are major factors which confer aminoglycoside resistance on bacteria. Distribution of genes encoding seven AMEs was investigated by multiplex PCR for 279 recent clinical isolates of enterococci derived from a university hospital in Japan. The aac(6h)-aph(2hh), which is related to high level gentamicin resistance, was detected at higher frequency in Enterococcus faecalis (42n5 %) than in Enterococcus faecium (4n3%). Almost half of E. faecalis and E. faecium isolates possessed ant(6 )-Ia and aph(3h)-IIIa. The profile of AME gene(s) detected most frequently in individual strains of E. faecalis was aac(6h)-aph(2hh)jant(6 )-Iajaph(3h)-IIIa, and isolates with this profile showed high level resistance to both gentamicin and streptomycin. In contrast, AME gene profiles of aac(6h)-Iijant(6 )-Iajaph(3h)-IIIa, followed by aac(6h)-Ii alone, were predominant in E. faecium. Only one AME gene profile of ant(6 )-Iajaph(3h)-IIIa was found in Enterococcus a ium. The ant(4h)-Ia and ant(9)-Ia, which have been known to be distributed mostly among Staphylococcus aureus strains, were detected in a few enterococcal strains. An AME gene aph(2hh)-Ic was not detected in any isolates of the three enterococcal species. These findings indicated a variety of distribution profiles of AME genes among enterococci in our study site.
INTRODUCTION
Enterococci are becoming an important cause of nosocomial infections including bacteraemia, surgical wound infection, and urinary tract infection in various regions of the world [1] . Recently, enterococci has become increasingly resistant to broad ranges of antimicrobial agents [2] , particularly, glycopeptides, beta-lactams, and aminoglycosides. Among these antibiotics, high level aminoglycoside resistance is reported worldwide, while glycopeptide or betalactam-resistant enterococci are prevalent mostly in the United States and European countries [3] . The presence of high level aminoglycoside resistance * Author for correspondence. results in the loss of synergy between cell wall synthesis inhibiting antibiotics (penicillins and glycopeptides) and aminoglycosides, which makes the treatment of serious enterococcal infections difficult [3] . Hence, epidemiologic survey of aminoglycoside resistance in enterococci is of significance for control of enterococcal infections.
Although enterococci are intrinsically resistant to low levels of aminoglycosides, high level resistance to aminoglycosides (MIC 2000 µg\ml) is mostly due to acquisition of genes encoding aminoglycoside modifying enzymes (AMEs) [4, 5] . The high level resistance to gentamicin, a key therapeutic aminoglycoside, in enterococci is associated with the aac(6h)-aph(2hh) which encodes the bifunctional AME, 198 N. Kobayashi and others AAC(6h)-APH(2hh) [6] . Kanamycin and streptomycin resistances in enterococci are mediated by APH(3h) and ANT [6] enzymes encoded by aph(3h)-IIIa and ant(6 )-Ia, respectively [4] . Moderate level resistance to gentamicin and other aminoglycosides in E. faecium is conferred by AAC(6h)-I and results in the marked decrease in penicillin-aminoglycoside synergism [7] . This AME gene is encoded by a chromosomal gene, aac(6h)-Ii in E. faecium [7] . Furthermore, aph(2hh)-Ic and aph(2hh)-Id which confer gentamicin resistance were recently identified in enterococci [8, 9] . The ant(3hh)-Ia (ant(3hh) (9) or aadA1) and ant(4h)-Ia gene, found in enterobacteria and Staphylococcus aureus, respectively, were also detected in a few enterococcal isolates [10, 11] . Although the prevalence of high level resistance to gentamicin or aac(6h)-aph(2hh) gene in enterococci has been reported in many studies [11] [12] [13] [14] , data on distribution of other AME genes in each enterococcal species are limited. In this study, to estimate the present status of aminoglycoside resistance in enterococci, we investigated distribution of seven AME genes in recent clinical isolates by multiplex PCR.
MATERIALS AND METHOD

Bacterial strains, identification and characterization
A total of 279 strains comprising 226 E. faecalis strains, 46 E. faecium strains, and 7 E. a ium strains were analysed. These bacterial strains were isolated from clinical specimens of 259 patients in Sapporo Medical University Hospital, Sapporo, Japan between January 1997 and December 1998. Approximately 50 % of the isolates were derived from urine, followed by other samples such as pus, bile, sputum, vaginal secretion, and gastric juice, while isolates from blood sample were only six strains. Identification of bacterial species and antimicrobial susceptibility tests were performed by the use of MicroScan WalkAway TM -96 (Baxter Diagnostics, Inc., West Sacrament, USA), and rapid ID32 STREP (bioMerieux) was also employed for several isolates. Identification of some E. faecalis and E. faecium strains were confirmed also by detecting with PCR enterococcal PBP5 genes, which are distinct between the two species [15, 16] , using E. faecalis specific primers (5h-CAGGGATTC-AAGCAGAAGGA-3h and 5h-TCACTGGTTCAGA-AGCGACTG-3h) and E. faecium specific primers (5h-GATGAATACCTCATTAGGTGA-3h and 5h-TGG-TTGTTCAGGATTTTCTTC-3h). During the study period, no vancomycin-resistant enterococcus was detected. MIC of the following aminoglycosides, gentamicin (GM), tobramycin (TOB), sisomicin (SISO), kanamycin (KM), streptomycin (SM) and spectinomycin (SPCM), were measured by broth microdilution assay as recommended by NCCLS [17] .
E. faecalis strains were genetically typed by arbitrarily primed PCR (AP-PCR) using ERIC2 primer, as described previously [18] . Aminoglycoside resistance genes in enterococci Multiplex PCR for detection of AME genes
In this study, multiplex PCR was employed to detect seven AME genes which have been reported to be distributed among enterococci and staphylococci [4, 8, 11, 19] . AME genes examined were aac(6h
and aph(3h)-IIIa. Among these, the ant(9)-Ia has been detected only in S. aureus (4) . The ant(4h)-Ia gene is also prevalent in S. aureus and has been reported only in a few enterococcal strains [11, 20] . AME genes such as aac(6h)-aph(2hh), aph(3h)-IIIa, and ant(3hh) (9) have been found in both S. aureus and enterococci [4, 10] . PCR primers specific for each AME gene are listed in Table 1 . Multiplex PCR was carried out using two reaction tubes for a single bacterial isolate. In the reaction I, four pairs of primers specific for aac(6h)-aph(2hh), ant(4h)-Ia, ant(9)-Ia, and aph(3h)-IIIa were contained and the reaction II tube contained three primer pairs for aac(6h)-Ii, ant(6 )-Ia, and aph(2hh)-Ic. These primers were designed to produce DNA fragments with distinct sizes from target AME genes in each reaction tube. Bacterial DNA was extracted using achromopeptidase as described previously [21] . Reaction mixture (100 µl) containing 1 µl template bacterial DNA, 2n5 unit of AmpliTaq DNA polymerase (Perkin-Elmer), 200 µ each of dNTP, 30 p each of primer, 10 m Tris-HCl (pH 8n3), 50 m KCl, and 1n5 m MgCl # were subjected to 30 PCR cycles of denaturation (94 mC, 1 min), annealing (55 mC, 1 min), and primer extension (72 mC, 2 min) in Thermal Cycler. The PCR products were analysed by electrophoresis on 1 % agarose gel stained with ethidium bromide.
RESULTS
Using multiplex PCR with 3 or 4 primer pairs designed in this study, individual AME gene-specific PCR products were generated and multiple PCR products in each reaction tube were clearly discriminated by their size, as shown in Figure 1 . Detection rate of each AME gene were summarized in possessed ant(6 )-Ia and aph(3h)-IIIa, although the number of isolates was small. The aph(2hh)-Ic, which was described recently as a novel GM resistance gene [8] , was not detected in any enterococci. Table 3 shows detection profiles of AME genes (AME gene pattern). In E. faecalis, 52n2 % of isolates was found to have any AME gene. The most frequently observed AME gene profile was aac(6h)-aph(2hh)jant(6 )-Iajaph(3h)-IIIa found in 35n8% of E. faecalis isolates. This AME gene profile was found more frequently detected in E. faecalis strains derived from blood (75 %, 3\4), bile (67 %, 6\9) and pus (53 %, 9\17) than in those from urine (36 %, 43\119), gastric juice (21 %, 5\24), vaginal secretion (17 %, 2\12), sputum and pharyngeal swab (20 %, 2\8) and all other specimens (31 %, 11\35). When clonality of E. faecalis was analysed by AP-PCR, the enterococci with this major AME gene profile were differentiated 
E. a ium (7 isolates) AME gene-negative
into 18 genetic types containing a dominant type that accounted for almost half of the isolates (data not shown). In E. faecium, 60n9 % of isolates possessed one or more AME genes in addition to aac(6h)-Ii. The AME gene profile of aac(6h)-Iijant(6 )-Iajaph(3h)-IIIa was most frequently detected, followed by that of aac(6h)-Ii. Furthermore, it was of note that 4 or 5 AME genes including aac(6h)-aph(2hh) were detected in the two E. faecium strains (e136, e185, Fig. 1 ). MIC of aminoglycosides was measured for enterococcal strains with representative AME gene patterns in order to confirm consistency with their aminoglycoside resistance phenotype (Table 4 ). Most strains with aac(6h)-aph(2hh) showed high level resistance (MIC 2000 µg\ml) to GM, as well as to SISO, KM, and TOB. Only one E. faecium strain (e136) with aac(6h)-aph(2hh) exhibited moderate level resistance to GM, SISO, and TOB. E. faecium having aac(6h)-Ii was moderately resistant to SISO and TOB, and strains with aph(3h)-IIIa were highly resistant to KM. Strains with ant(6 )-Ia and ant(9)-Ia were highly resistant to SM and SPCM, respectively. Thus, resistance to aminoglycosides of enterococcal strains were generally correlated with the presence of individual AME genes. However, the high level resistance to GM, SISO, KM, and TOB of E. faecium strain e129, SM resistance of E. faecium strain e30, and SPCM resistance of E. faecalis strain e6 could not be explained by the AME genes detected in this study. As for these three strains, an attempt was made by PCR to detect other AME * Resistance break points were determined based on description or susceptibility data reported previously [11, 32] . In this study, MIC more than 2000 µg\ml of aminoglycosides was regarded as high level resistance, as described previously [3, 13, 19] .
genes : aph(2hh)-Id, aac(3)-Ia, aac(3)-IIa, aac(3)-IIIa, aac(3)-IVa, aac(6h)-IIa, aac(2h)-Ia, and ant(2hh)-Ia for e129 ; and aph(3hh)-I, aph(6 )-I, ant(3hh)(9)(aadA1)
, aadA2, aadA3, aadA4, aadA5, aadA6, and aadA7 for e6 and e30. However, none of these AME genes were detected in these strains.
DISCUSSION
Since its first emergence in late 1970s, enterococci with high level GM resistance have been disseminated in most countries and its incidence was remarkably increased in 1990s as shown in some studies [5, 20, 22, 23] . Since the high level of aminoglycoside resistance is recognized as a clinically serious problem, routine examination as well as surveillance of clinical isolates of enterococci are essential for the choice of appropriate therapy and infection control. Some genes encoding AMEs, major determinants of aminoglycoside resistance of bacteria, have been identified by PCR [10, 20] . Furthermore, in order to detect AME genes in a single strain, multiplex PCR using several pairs of primers in one reaction mixture was developed [24, 25] . Using this method, prevalence of aac(6h)-aph(2hh), aph(3h)-IIIa, and ant(4h)-Ia were examined for enterococci, group A streptococci, and methicillin resistant S. aureus. In the present study, we further developed a system of the multiplex PCR for enterococci to detect six AME genes, to obtain comprehensive knowledge on prevalence of AME genes. The multiplex PCR used in this study was demonstrated to be feasible for detection and differentiation of at least six AME genes without generating non-specific product, although isolates with aph(2hh)-Ic was not detected. High level GM resistance in enterococci is primarily associated with aac(6h)-aph(2hh) gene encoding bifunctional enzyme AAC(6h)-APH(2hh), which confer also resistance to clinically useful aminoglycosides (e.g. TOB, amikacin, netilmicin) [6] . The aac(6h)-aph(2hh) gene is considered to have been conveyed to both enterococci and staphylococci via plasmid and transposons [5] . Incidence of recent enterococcal isolates showing high level GM resistance varies depending on countries as well as medical facilities. In a large scale survey involving 27 European countries, percentage of GM-highly resistant enterococcal isolates varied by country ranging from 1-49 % (mean 22n6 %), and by species (19n7%, E. faecalis and 13n6%, E. faecium) [14] . Another survey on isolates from European university hospitals reported the incidence of strains with high level GM resistance being 32 % and 22 % in E. faecalis and E. faecium, respectively [26] . The nationwide survey in the United States indicated the incidence of GM-highly resistant strains of 26 % and 30n8% in E. faecalis and E. faecium, respectively [13] . In a study on E. faecalis isolates from a Japanese university hospital, 22n3 % of isolates showed high level resistance to GM [27] . Since high level GM resistance is generally found at less than 30 % of isolates as described above, the incidence (42n5%) of aac(6h)-aph(2hh) in E. faecalis in our present study appears to be relatively high. Considering that aac(6h)-aph(2hh) was found in genetically distinct 18 groups of E. faecalis in our study, this AME gene is suggested to be disseminated among various clones of E. faecalis, which then spread in the university hospital where our present study was done. In contrast, the incidence of E. faecium with this AME gene was 4n3 %, which was markedly lower than not only that of E. faecalis in this study but also those of E. faecium with high level gentamicin resistance in other epidemiologic studies [13, 14] . Our results suggested that aminoglycoside resistant E. faecium may not be a serious nosocomial pathogen, compared to E. faecalis in this hospital.
The ant(6 )-Ia and aph(3h)-IIIa responsible for resistance to SM and KM, respectively, have been commonly found in enterococci [11] . In our present study, it was of note that ant(6 )-Ia was detected together with aac(6h)-aph(2hh) in 37n6% of E. faecalis, and together with aac(6h)-Ii in 53n7% of E. faecium isolates. Since E. faecalis with aac(6h)-aph(2hh) and ant(6 )-Ia are highly resistant to both GM and SM, there will be no bactericidal regimen which is aimed at synergic activity between aminoglycosides and betalactams [3] . Similarly, E. faecium with aac(6h)-Ii and ant(6 )-Ia may also restrict the choice of therapy, because AAC(6h)-I also reduce the synergy between beta-lactams and aminoglycosides with free 6h-amino groups [7] . Particularly, detection rate of E. faecalis with aac(6h)-aph(2hh) and ant(6 )-Ia in the present study was higher than those of E. faecalis that are resistant to both GM and SM reported in other studies [12, 24] . Therefore, in our hospital, precaution should be taken for such enterococci, although enterococci with vancomycin and beta-lactam resistance are still rare in Japan [27, 28] . In addition, it was noted in our present study that a few E. faecalis strains were resistant to ampicillin without producing beta-lactamase, although the mechanism of resistance is yet to be clarified (unpublished data). These strains mostly possessed aac(6h)-aph(2hh) together with other AME gene(s) (ant(6 )-Ia, aph(3h)-IIIa or ant(4h)-Ia). Hence it is also important to pay attention to beta-lactam resistance in E. faecalis viewed from the significance of synergic action with aminoglycosides.
In the present study, two AME genes, ant(4h)-Ia and ant(9)-Ia which are commonly found in S. aureus were detected in a few enterococcal isolates. The ant(4h)-Ia has been detected only in an E. faecalis isolate and an E. faecium isolate [11, 20] , and the ant(9)-Ia, encoding ANT(9)-I conferring specific by resistance to spectinomycin has never been found in enterococci. It was also noted that aad(3hh)(9)(aadA) gene which has been reported to exist in Gramnegative bacteria and S. aureus was recently detected in E. faecalis [10] . These findings indicated that all AME genes but aph(3hh)-I distributed in staphylococci have been already found in enterococci. These facts may support a view that AME genes in enterococci might have been originated from staphylococci [5] .
MIC of aminoglycosides measured for representative enterococci were almost consistent with the AME gene profile revealed by multiplex PCR in this study. However, high level resistance to GM, SM and SPCM for three strains of e129, e30 and e6, respectively, was unexplainable by the presence of AME genes detected in this study. Furthermore, AME genes such as aph(2hh)-Id, aac(3)-Ia, aph(3hh)-I and ant(3hh)(9) that have been previously described in enterococci or in other bacterial species were not detected by PCR. The presence of novel AME genes or genetic variation of the known AME genes may be possible. In addition, existence of resistance mechanism other than AME including ribosomal mutation reported for SM resistance [29] have been suggested. Thus, aminoglycoside resistance mechanisms of enterococci seem to be considerably variable, and surveillance of aminoglycoside resistance as well as further analysis on resistance mechanisms seem to be all the more important.
